Search
for
Sort by
Research 151–180 of 429
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Biology of the Hair Follicle: The Basics
- Evidence-based approach to cutaneous hyperandrogenism in women
- The Molecular Mechanism Underlying the Proliferating and Preconditioning Effect of Vitamin C on Adipose-Derived Stem Cells
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Optimized Nanostructured Lipid Carriers for Dutasteride Delivery: Improving Therapeutic Efficiency and Minimizing Adverse Effects
- Human and animal cells under influence of different lighting and stimulus
- British Society for Dermatopathology
- UTILIDADES DE LA ESPIRONOLACTONA COMO FÁRMACO ANTIANDROGÉNICO
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Genetic Defects of Female Sexual Differentiation
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Sildenafil: Looking Beyond Erectile Dysfunction: A Dermatological Perspective
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- 294 Extensive alopecia areata is reversed by IL-12/23p40 cytokine antagonism
- Medikamentöse Therapie des benignen Prostatasyndroms
- Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants
- Finasteride in Hidradenitis Suppurativa: A “Male” Therapy for a Predominantly “Female” Disease.
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health
- Valproate‐associated hair abnormalities: Pathophysiology and management strategies
- White Lupin Cluster Root Acclimation to Phosphorus Deficiency and Root Hair Development Involve Unique Glycerophosphodiester Phosphodiesterases
- The association of medications and supplements with human male reproductive health: a systematic review